Conventional and Real-Time PCR Targeting blaOXA Genes as Reliable Methods for a Rapid Detection of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains

Multidrug-resistant Acinetobacter baumannii, particularly those producing carbapenemases, are spread worldwide. A reliable detection of carbapenemases is essential to choose the appropriate antimicrobial therapy and, consequently, prevent the dissemination of carbapenem-resistant strains. The aim of this study is to examine the molecular basis of the carbapenem resistance mechanism and estimation of conventional PCR and real-time PCR usefulness for the detection of oxacillinases when compared to phenotypic carbapenemases detection. The following methods were evaluated: the CarbAcineto NP test, Carbapenem Inactivation Method, CPO panels of semiautomated antimicrobial susceptibility testing method on the BD Phoenix™ M50 system, conventional Polymerase Chain Reaction and real-time PCR. The eazyplex® SuperBug complete A assay was used as the reference method. Among the tested strains, 39 (67.2%) carried the blaOXA-40 gene, while the blaOXA-23 gene was noted amongst 19 (32.8%) isolates. The diagnostic sensitivities of the studied assays were as follows: CarbAcineto NP—65.5%; CIM—100%; CPO—100%; conventional PCR—100%; real-time PCR—100%.

[1]  E. Gospodarek-Komkowska,et al.  An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria , 2021, Antibiotics.

[2]  S. Joshi,et al.  Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review , 2021, Journal of applied microbiology.

[3]  A. Laudy,et al.  Analysis of blaCHDL Genes and Insertion Sequences Related to Carbapenem Resistance in Acinetobacter baumannii Clinical Strains Isolated in Warsaw, Poland , 2021, International journal of molecular sciences.

[4]  A. Nguyen,et al.  Overexpression of blaOXA-58 Gene Driven by ISAba3 Is Associated with Imipenem Resistance in a Clinical Acinetobacter baumannii Isolate from Vietnam , 2020, bioRxiv.

[5]  M. Wootton,et al.  Rapid detection of OXA-23-like, OXA-24-like and OXA-58-like carbapenemases from Acinetobacter species by real-time PCR. , 2020, Journal of Hospital Infection.

[6]  S. Songca,et al.  Molecular Detection of Carbapenemase-Encoding Genes in Multidrug-Resistant Acinetobacter baumannii Clinical Isolates in South Africa , 2020, International journal of microbiology.

[7]  R. Bonomo,et al.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace , 2020, Biomolecules.

[8]  Charles K. Cooper,et al.  Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates , 2020, Journal of Clinical Microbiology.

[9]  Woojun Park,et al.  Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy , 2017, Journal of Microbiology.

[10]  Gina K. Thomson,et al.  High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases , 2017, Journal of Clinical Microbiology.

[11]  W. Hryniewicz,et al.  Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  K. Carroll,et al.  Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli , 2017, Journal of Clinical Microbiology.

[13]  Samyyia Abrar,et al.  Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan. , 2017, Microbial pathogenesis.

[14]  ProticDragana,et al.  Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle? , 2016 .

[15]  M. Zdravković,et al.  Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle? , 2016, Surgical infections.

[16]  J. Smajlović,et al.  Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii , 2014, Medical archives.

[17]  Paolo Visca,et al.  Acinetobacter baumannii: evolution of a global pathogen. , 2014, Pathogens and disease.

[18]  S. Uzunović,et al.  Carbapenemases in Gram-Negative Bacteria: Laboratory Detection and Clinical Significance , 2014, BioMed research international.

[19]  P. Nordmann,et al.  CarbAcineto NP Test for Rapid Detection of Carbapenemase-Producing Acinetobacter spp , 2014, Journal of Clinical Microbiology.

[20]  A. Peleg,et al.  Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies , 2013, Expert review of anti-infective therapy.

[21]  Rui Wang,et al.  Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.

[22]  M. Iacono,et al.  The genomics of Acinetobacter baumannii: Insights into genome plasticity, antimicrobial resistance and pathogenicity , 2011, IUBMB life.

[23]  P. Nordmann,et al.  Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.

[24]  P. Nordmann,et al.  Diversity, Epidemiology, and Genetics of Class D β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.

[25]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[26]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[27]  M. Kaufmann,et al.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.

[28]  N. Woodford,et al.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. , 2006, International journal of antimicrobial agents.

[29]  eazyplex SuperBug kits for detecting carbapenemase-producing organisms , 2022 .